Late reversal reaction with resistant Mycobacterium leprae : an emerging paradigm

Abstract

Keywords

Late reversal reaction Live bacilli Resistant bacilli relapse steroid MDT

Get full access to this article

View all access options for this article.

References

Save

Dighe

Natrajan

, et al. Association of viable Mycobacterium leprae with Type 1 reaction in leprosy. Lepr Rev 2016; 87: 78–92.

Linder

Zia

Kern

, et al. Relapses vs. reactions in multibacillary leprosy: proposal of new relapse criteria. Trop Med Int Health 2008; 13: 295–309.

World Health Organization. WHO model prescribing information: drugs used in leprosy, Geneva: WHO, 1998.

Shetty

Wakade

Antia

. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients. Lepr Rev 2001; 72: 337–344.

Lini

Shankernarayan

Dharmalingam

. Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases. J Med Microbiol 2009; 58: 753–759.

World Health Organization. WHO Expert Committee on leprosy: eighth report, Geneva: WHO, 2012.

Vijayakumaran

Manimozhi

Jesudasan

. Incidence of late lepra reaction among multibacillary leprosy patients after MDT. Int J Lepr Other Mycobact Dis 1995; 63: 18–22.

Waters

. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy. Lepr Rev 2001; 72: 250–253.

Naafs

van Hees

. Leprosy type 1 reaction (formerly reversal reaction). Clin Dermatol 2016; 34: 37–50.

10.

Jopling

Mc Dougall

. Handbook of Leprosy, 5th edn. Delhi: CBS Publishers and Distributors, 1996; 82.

11.

Grosset

. Progress in the chemotherapy of leprosy. Int J Lepr Other Mycobact Dis 1994; 62: 268–277.

12.

Grosset

Guelpa-Lauras

C-C

Bobin

, et al. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampicin. Int J Lepr 1989; 57: 607–614.

13.

Reddy

Cherian

. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction. Indian J Lepr 1991; 63: 61–69.

14.

Shetty

Khambati

Ghate

, et al. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; Part 3–study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT+ steroids vs MDT alone, assessed at 6 months post–release from 12 months MDT. Lepr Rev 2010; 80: 41–59.

15.

Levy

Grosset

. Chemotherapy of leprosy: progress since the Orlando Congress, and prospects for the future. Int J Lepr Other Mycobact Dis 1996; 64: S80–88.